High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$577K
$577,173
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2026-03-02
$508
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-03-02 | $508 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $1,006 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $295 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $6,602 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $7,335 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2026-03-02
$122
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-03-02 | $122 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2026-03-02
$8,145
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-03-02 | $8,145 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2026-03-02
$1,916
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-03-02 | $1,916 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Panacea Innovation Ltd
• 10% Owner
Discretionary Sell
2026-01-12
$489,019
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2026-01-12 | $489,019 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
10% Owner
Other
|
2025-11-28 | $322,147 | M | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
10% Owner
Other
|
2025-11-28 | $5 | M | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2025-11-17
$21,691
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2025-11-17 | $21,691 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2025-11-17
$1,121
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2025-11-17 | $1,121 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2025-11-17
$976
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2025-11-17 | $976 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2025-11-17 | $739 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2025-11-17 | $37,699 | S | Form 4 |